CN1210049C - Chinese medicine composition for treating diabetes - Google Patents
Chinese medicine composition for treating diabetes Download PDFInfo
- Publication number
- CN1210049C CN1210049C CN 02146652 CN02146652A CN1210049C CN 1210049 C CN1210049 C CN 1210049C CN 02146652 CN02146652 CN 02146652 CN 02146652 A CN02146652 A CN 02146652A CN 1210049 C CN1210049 C CN 1210049C
- Authority
- CN
- China
- Prior art keywords
- radix
- portions
- chinese medicine
- medicine composition
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicine composition for treating diabetes, which has the components by weight percentage of 40 to 300 portions of ginseng, 5 to 100 portions of aweto, 40 to 300 portions of pseudostellaria, 30 to 240 portions of Rhizoma Ligustici, 40 to 300 portions of trichosanthes root, 60 to 500 portions of rehmanniae root, 40 to 300 portions of eupatorium, 30 to 240 portions of red sage root, 30 to 240 portions of figwort root, 40 to 300 portions of white atractylodes rhizome and 60 to 500 portions of coptis. Verified by clinical examples, the total effective rate of the medicine of the present invention is 97%.
Description
Invention field
The present invention relates to a kind of Chinese medicine composition for the treatment of diabetes.
Background technology
Diabetes are clinical commonly encountered diseases and frequently-occurring diseases.According to World Health Organization (WHO) prediction, by 2005, global diabetic turned over than present 1.5 hundred million, and the patient mainly concentrates on Asian countries such as India and China.
Diabetes are to be a kind of syndrome of basic biochemical character to continue hyperglycemia, are to cause apoplexy, heart disease, nephropathy, blind, the one of the main reasons of cutting serious diseases such as foot.
Diabetes are divided into two kinds: type i diabetes is owing to the absorption of insulin deficiency causes, the patient must can be survived by insulin injection.Type ii diabetes mainly is because insulin secretion relative deficiency or generation insulin resistant cause the glucose that contains high concentration in the blood, As time goes on, cause serious damage will for many organs.
Summary of the invention
The inventor in conjunction with clinical practice, has researched and developed the Chinese medicine composition of fruitful treatment diabetes on the basis of handed down from the older generations of the family secret proved recipe.
Chinese medicine composition of the present invention comprises:
40-300 weight portion Radix Panacis Quinquefolii;
5-100 weight portion Cordyceps;
40-300 weight portion Radix Pseudostellariae;
30-240 weight portion Rhizoma Chuanxiong;
40-300 weight portion Radix Trichosanthis;
60-500 weight portion Radix Rehmanniae;
40-300 weight portion Herba Eupatorii;
30-240 weight portion Radix Salviae Miltiorrhizae;
30-240 weight portion Radix Scrophulariae;
The 40-300 weight portion Rhizoma Atractylodis Macrocephalae; With
60-500 weight portion Rhizoma Coptidis.
Compositions of the present invention preferably includes:
70-130 weight portion Radix Panacis Quinquefolii;
20-40 weight portion Cordyceps;
70-130 weight portion Radix Pseudostellariae;
50-100 weight portion Rhizoma Chuanxiong;
70-130 weight portion Radix Trichosanthis;
120-200 weight portion Radix Rehmanniae;
70-130 weight portion Herba Eupatorii;
50-100 weight portion Radix Salviae Miltiorrhizae;
50-100 weight portion Radix Scrophulariae;
The 70-130 weight portion Rhizoma Atractylodis Macrocephalae; With
120-200 weight portion Rhizoma Coptidis.
The present composition most preferably comprises:
100 weight portion Radix Panacis Quinquefoliis;
30 weight portion Cordyceps;
100 weight portion Radix Pseudostellariaes;
75 weight portion Rhizoma Chuanxiongs;
100 weight portion Radix Trichosanthis;
150 weight portion Radix Rehmanniae;
100 weight portion Herba Eupatoriis;
75 weight portion Radix Salviae Miltiorrhizaes;
75 weight portion Radix Scrophulariaes;
The 100 weight portion Rhizoma Atractylodis Macrocephalaes; With
150 weight portion Rhizoma Coptidis.
Wherein Radix Rehmanniae is preferably used the Radix Rehmanniae.
Medicine of the present invention has the effect of blood sugar lowering, blood fat reducing, human body immunity improving power.
Can according to a conventional method above-mentioned composition be made any suitable dosage form, for example the watered pill, capsule, powder, oral liquid, concentrated capsule etc.
For example above-mentioned raw materials can be pulverized, sieve, make the watered pill.
Amount of drug of the present invention is according to variations such as patient's concrete condition (for example height of blood glucose, age, body weight, the course of disease, toleration etc.), pharmaceutical dosage form, Blood glucose control situations.For example, under the situation of the watered pill, taking dose is generally 2-6g/ time, 2-4 time/day.Therapeutic Method be 15 days be a course of treatment, can any antidiabetic drug during the light moderate of the blood glucose rising person treatment, cooperate dietetic therapy in case of necessity.Long-term dependence antidiabetic drug or insulin-dependent patient, can be in the medication process, examine blood glucose, glucose in urine variation, reduce former antidiabetic drug gradually, until all removing, to have the inclination, the patient of brain, kidney, neurological complication, the overall principle adopts combination of Chinese and Western medicine principle, based on Chinese traditional treatment.
Embodiment
Followingly the present invention is described, is noted that these embodiment only by being used for illustrative purposes, do not constitute any restriction to the scope of the invention according to embodiment.
Embodiment 1
Radix Panacis Quinquefolii 100 weight portions, Cordyceps 30 weight portions, Radix Pseudostellariae 100 weight portions, Rhizoma Chuanxiong 75 weight portions, Radix Trichosanthis 100 weight portions, the Radix Rehmanniae 150 weight portions, Herba Eupatorii 100 weight portions, Radix Salviae Miltiorrhizae 75 weight portions, Radix Scrophulariae 75 weight portions, the Rhizoma Atractylodis Macrocephalae 100 weight portions and Rhizoma Coptidis 150 weight portions, all medicated powder is broken, sieve, make the watered pill.
Embodiment 2
Radix Panacis Quinquefolii 120 weight portions, Cordyceps 25 weight portions, Radix Pseudostellariae 100 weight portions, Rhizoma Chuanxiong 75 weight portions, Radix Trichosanthis 130 weight portions, the Radix Rehmanniae 180 weight portions, Herba Eupatorii 90 weight portions, Radix Salviae Miltiorrhizae 70 weight portions, Radix Scrophulariae 70 weight portions, the Rhizoma Atractylodis Macrocephalae 95 weight portions and Rhizoma Coptidis 150 weight portions, all medicated powder is broken, sieve, make the watered pill.
Evaluation of clinical curative effect
Clinical data
Treatment group patient 60 examples, male 30 examples, women 30 examples; Age 20-30 year 2 examples, 31-40 year 15 examples, 43 examples more than 51 years old; The course of disease is the longest 12 years, and is the shortest 1 month.
Therapeutic outcome
1, efficacy assessment standard
Produce effects: transference cure or obviously improvement after the course of treatment, the blood sugar recovery normal value, or descend 50%, glucose in urine (-) before the treatment.
Effectively: doing well,improving or basic elimination the after the course of treatment, fasting glucose descends 30%, glucose in urine ±-+.
Invalid: after the course of treatment sx or with treatment before compare not have obviously and improve, fasting glucose descends＜15%.
2, total effects
Produce effects 39 examples, effective 19 examples, invalid 2 examples, total effective rate 97%.
Test case for example
The king * *, the man 51 years old, suffered from diabetes 3 years, obstinate.Symptom before the medication: the daily drink amount is huge.Body is day by day become thin, weak, the sexual impotence of body lazyness.Glucose in urine (++ ++), 320 milligrams/L of blood glucose.1 course of treatment of administration, symptom obviously alleviates, and obeys 3 courses of treatment altogether, and symptom is eliminated fully, and glucose in urine transfers feminine gender to, and blood glucose is normal.Followed up a case by regular visits to 1 year, normal.
Claims (6)
1, a kind of Chinese medicine composition for the treatment of diabetes, this Chinese medicine composition is made by the following weight proportion raw material:
40-300 part Radix Panacis Quinquefolii;
5-100 part Cordyceps;
40-300 part Radix Pseudostellariae;
30-240 part Rhizoma Chuanxiong;
40-300 part Radix Trichosanthis;
60-500 part Radix Rehmanniae;
40-300 part Herba Eupatorii;
30-240 part Radix Salviae Miltiorrhizae;
30-240 part Radix Scrophulariae;
40-300 part Rhizoma Atractylodis Macrocephalae; With
60-500 part Rhizoma Coptidis.
According to the Chinese medicine composition of claim 1, it is characterized in that 2, the weight proportion of raw material is:
70-130 part Radix Panacis Quinquefolii;
20-40 part Cordyceps;
70-130 part Radix Pseudostellariae;
50-100 part Rhizoma Chuanxiong;
70-130 part Radix Trichosanthis;
120-200 part Radix Rehmanniae;
70-130 part Herba Eupatorii;
50-100 part Radix Salviae Miltiorrhizae;
50-100 part Radix Scrophulariae;
70-130 part Rhizoma Atractylodis Macrocephalae; With
120-200 part Rhizoma Coptidis.
According to the Chinese medicine composition of claim 1, it is characterized in that 3, the weight proportion of raw material is:
100 parts of Radix Panacis Quinquefoliis;
30 parts of Cordyceps;
100 parts of Radix Pseudostellariaes;
75 parts of Rhizoma Chuanxiongs;
100 parts of Radix Trichosanthis;
150 portions of Radix Rehmanniae;
100 portions of Herba Eupatoriis;
75 parts of Radix Salviae Miltiorrhizaes;
75 portions of Radix Scrophulariaes;
100 parts of Rhizoma Atractylodis Macrocephalaes; With
150 portions of Rhizoma Coptidis.
4, according to each Chinese medicine composition among the claim 1-3, wherein Radix Rehmanniae is selected the Radix Rehmanniae for use.
5, according among the claim 1-3 each Chinese medicine composition, it can be any clinical common formulations.
6, the method for each Chinese medicine composition among the preparation claim 1-3 comprises above-mentioned raw materials is pulverized, and sieves, and makes the watered pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02146652 CN1210049C (en) | 2002-11-01 | 2002-11-01 | Chinese medicine composition for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02146652 CN1210049C (en) | 2002-11-01 | 2002-11-01 | Chinese medicine composition for treating diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1493321A CN1493321A (en) | 2004-05-05 |
| CN1210049C true CN1210049C (en) | 2005-07-13 |
Family
ID=34232819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02146652 Expired - Fee Related CN1210049C (en) | 2002-11-01 | 2002-11-01 | Chinese medicine composition for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1210049C (en) |
-
2002
- 2002-11-01 CN CN 02146652 patent/CN1210049C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1493321A (en) | 2004-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100342889C (en) | Chinese medicine for treating gout | |
| CN1726929A (en) | Compsn. of medication for treating diabetes | |
| CN1943737A (en) | A Chinese traditional medicinal composition used for treatment of nephritis and its preparation method | |
| CN1210049C (en) | Chinese medicine composition for treating diabetes | |
| CN1107711A (en) | Hypoglycemic compound capsule | |
| CN1233364C (en) | Chinese medicine for treating digestive ulcerating sore and its preparation method | |
| CN1285367C (en) | Medicinal preparation for treating diabetes and its preparation method | |
| CN1272054C (en) | Medicine for treating diabetes and its preparing process | |
| CN1903240A (en) | Medicinal use of Aralia continentalis kitag | |
| CN1087946C (en) | Medicine for curing diabetes | |
| CN1274338C (en) | Traditional Chinese medicine for treating aplastic anemia and its preparation process | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN1475261A (en) | Medicine for treating gastral cavity pain and its preparation method | |
| CN1176108A (en) | Kidney-warming and Yang-activating medicine | |
| CN1333044A (en) | Wasting-thirst hypoglycemic preparation | |
| CN1126558C (en) | Medicine for treating kidney damage caused by immunological disease lupus erythematosus | |
| CN1180775C (en) | Compound stomatocase-treating capsule | |
| CN1074928C (en) | Medicine for curing hemiplegia and its preparing process | |
| CN1513539A (en) | Preparation technology of supplementing kind capsule | |
| CN1097333A (en) | A kind of pure plant health preparation glycolipid disappears and method for making | |
| CN1056308C (en) | Medicine for adjusting cranial nerve function | |
| CN1682980A (en) | Medicine for treating diabetes and its preparing method | |
| CN1147397A (en) | Chinese patent drug for various cancers and tumors | |
| CN1657065A (en) | Soft capsule for treating vascular headaehe | |
| CN1239179C (en) | Chinese medicine for treating diabetes and preparation method therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |